Theresa House
Family · Humble, TXNPI 1861948036
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,375 and has fallen 98.6% since, to $19 in 2024. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$384
- Lilly USA, LLC$325
- Novo Nordisk$300
- GSK$233
- AstraZeneca$232
- Amgen$206
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,598100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $384 |
| Lilly USA, LLC | 19 | $325 |
| Novo Nordisk | 17 | $300 |
| GSK | 14 | $233 |
| AstraZeneca | 6 | $232 |
| Amgen | 13 | $206 |
| Sanofi-aventis U.S. LLC | 11 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $154 |
| Abiomed | 2 | $140 |
| Amarin Pharma, Inc. | 7 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $123 |
| Bayer | 6 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Novartis | 5 | $87 |
| Abbott | 4 | $78 |
| Eisai Inc. | 4 | $67 |
| Jazz Pharmaceuticals Inc. | 4 | $66 |
| Johnson & Johnson | 4 | $65 |
| Dexcom, Inc. | 4 | $63 |
| Exact Sciences | 3 | $57 |
| Paratek Pharmaceuticals, Inc. | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $54 |
| Idorsia Pharmaceuticals US Inc | 4 | $54 |
| Boehringer Ingelheim | 3 | $49 |
| Currax Pharmaceuticals LLC | 3 | $42 |
| Bausch Health US, LLC | 3 | $35 |
| Sunovion Pharmaceuticals Inc. | 3 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Genentech USA, Inc. | 2 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Tolmar, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Corium, LLC | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$128
How this compares
$3,610 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 28 | $587 |
| Tamsulosin Hcl | 15 | $323 |
| Pantoprazole Sodium | 13 | $321 |
| Amlodipine Besylate | 17 | $168 |
| Lisinopril | 12 | $166 |
| Levothyroxine Sodium | 19 | $149 |
Paid to pharmacies, not to this prescriber.
Other family in Humble
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.